A new method for the non-invasive monitoring of sodium levels in real time could enhance the management of dehydration, neurological disorders, and other health conditions

A research team led by Associate Professor Ayako Okado-Matsumoto from the Toho University’s Department of Biology, has made an important breakthrough in understanding Dementia with Lewy Bodies (DLB), in collaboration with Professor Ryuji Sakakibara from the Department of Neurology, Sakura Medical Center, and Professors Hitoshi Nukada and Soroku Yagihashi from the Department of Exploratory Medicine on Nature, Life and Man, Toho University The teamdiscovered something remarkable about a specific protein in patient’s blood. The researchers found that people with DLB have significantly lower amount of a protein called α-synuclein (alpha synuclein) in their red blood cells compared to healthy people and those with other brain diseases like Alzheimer's or Parkinson's disease. α-synuclein is a protein that becomes problematic when it builds up abnormally in brain cells, contributing to various neurological conditions.

Two anonymous $25 million estate gifts are building momentum for UVA's Paul and Diane Manning Institute of Biotechnology. The gifts also enabled UVA Health to top its $1 billion fundraising goal in UVA's Honor the Future campaign.

The grant will launch a community-led queen conch aquaculture facility in Eleuthera, The Bahamas, in partnership with The Island School’s Cape Eleuthera Institute. Focused on restoring declining queen conch populations—vital to Caribbean ecosystems and coastal food economies—the project is part of a larger mission to transform food systems and strengthen coastal resilience through sustainable aquaculture. It builds on the Queen Conch Lab’s growing network of 10 community-based farms across the Caribbean, underscoring the species’ importance to ocean health, food security, and cultural identity.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) welcomed 7,800 physicians, technologists, pharmacists, laboratory professionals, scientists, industry leaders and patients this week at its 2025 Annual Meeting in New Orleans, themed “Accelerating the Cure.” With the rapid pace of evolution in the specialty, the meeting provided a key forum for sharing new research and ideas and building connections.